Shandong Wohua Pharmaceutical Co.Ltd(002107)
Prior approval opinions of independent directors on relevant matters
As an independent director of Shandong Wohua Pharmaceutical Co.Ltd(002107) (hereinafter referred to as the company), we have carefully examined the relevant proposals proposed by the company to be submitted to the 17th meeting of the sixth board of directors for deliberation in accordance with the rules for independent directors of listed companies, the guidelines for self regulatory supervision of Shenzhen listed companies No. 1 – standardized operation of listed companies on the main board and other laws and regulations, as well as the relevant provisions of the articles of association, And based on the position of independence, objectivity and impartiality, express the following prior approval opinions on the following related matters:
1、 Prior approval opinions on providing loan extension to holding subsidiaries
The company’s provision of loan extension to the holding subsidiary Liaoning wohua Kangchen Pharmaceutical Co., Ltd. is a normal business behavior, and the company can obtain income. As other shareholders of Liaoning wohua Kangchen Pharmaceutical Co., Ltd. Qingdao kangjisheng Investment Co., Ltd. are related parties of the company, the company does not provide loans to Liaoning wohua Beijing Konruns Pharmaceutical Co.Ltd(603590) Co., Ltd. in the same proportion this time. The company provides loans to Liaoning wohua Kangchen Pharmaceutical Co., Ltd. separately, which constitutes a related party transaction, and the decision-making procedures for related party transactions shall be performed. Therefore, we agree to submit the matter to the board of directors of the company for deliberation. independent director:
LV Wei, Peng Juan, Li Junde
January 7, 2002
